ID

38210

Beschrijving

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry; ODM derived from: https://clinicaltrials.gov/show/NCT02302742

Link

https://clinicaltrials.gov/show/NCT02302742

Trefwoorden

Versies (1)
  1. 27-09-19 27-09-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

27 september 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Cancer NCT02302742

Engels

Eligibility Breast Cancer NCT02302742

1 Formulieren  
Criteria
Beschrijving

Criteria

triple negative breast cancer
Beschrijving

Triple Negative Breast Neoplasms

Datatype

boolean

Alias
UMLS CUI [1]
C3539878
er/pr <10% and her negative per current asco/cap guidelines
Beschrijving

Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative

Datatype

boolean

Alias
UMLS CUI [1,1]
C0034804
UMLS CUI [1,2]
C0439165
UMLS CUI [2,1]
C0034833
UMLS CUI [2,2]
C0439165
UMLS CUI [3]
C4087185
stages i-iv
Beschrijving

TNM Breast tumor staging

Datatype

boolean

Alias
UMLS CUI [1]
C0474926
any age at diagnosis
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
patient must be within 5 years of diagnosis
Beschrijving

Diagnosis Timespan

Datatype

boolean

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0872291
eligible regardless of genetic testing status
Beschrijving

Patient eligible for clinical trial Independent of Genetic testing

Datatype

boolean

Alias
UMLS CUI [1,1]
C1302261
UMLS CUI [1,2]
C0332291
UMLS CUI [1,3]
C0679560
genetic testing recommended for patients meeting nccn and medicare guidelines
Beschrijving

Genetic testing Recommended

Datatype

boolean

Alias
UMLS CUI [1,1]
C0679560
UMLS CUI [1,2]
C0034866
and/or
Beschrijving

ID.8

Datatype

boolean

germline mutation carriers
Beschrijving

Germ-Line Mutation Carrier

Datatype

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C2985478
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
Beschrijving

HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site

Datatype

boolean

Alias
UMLS CUI [1,1]
C0677776
UMLS CUI [1,2]
C0017337
UMLS CUI [2]
C0596223
UMLS CUI [3]
C0694888
UMLS CUI [4]
C0079419
UMLS CUI [5]
C1835898
UMLS CUI [6,1]
C1302261
UMLS CUI [6,2]
C0332291
UMLS CUI [6,3]
C0872338
healthy patients harboring mutations also eligible
Beschrijving

Healthy Volunteers Mutation | Patient eligible for clinical trial

Datatype

boolean

Alias
UMLS CUI [1,1]
C1708335
UMLS CUI [1,2]
C0026882
UMLS CUI [2]
C1302261
there is no time limit from the time of diagnosis of cancer and enrollment.
Beschrijving

Time limit Absent | Cancer diagnosis | Enrollment

Datatype

boolean

Alias
UMLS CUI [1,1]
C0332186
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0920688
UMLS CUI [3]
C1516879
eligible regardless of personal history of cancer
Beschrijving

Patient eligible for clinical trial Independent of Cancer History

Datatype

boolean

Alias
UMLS CUI [1,1]
C1302261
UMLS CUI [1,2]
C0332291
UMLS CUI [1,3]
C1512706
exclusion criteria include:
Beschrijving

Exclusion Criteria

Datatype

boolean

Alias
UMLS CUI [1]
C0680251
triple negative breast cancer -patient is not within five years of diagnosis
Beschrijving

Triple Negative Breast Neoplasm Previous

Datatype

boolean

Alias
UMLS CUI [1,1]
C3539878
UMLS CUI [1,2]
C0205156
germline mutation carriers:
Beschrijving

Germ-Line Mutation Carrier

Datatype

boolean

Alias
UMLS CUI [1,1]
C0206530
UMLS CUI [1,2]
C2985478
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
Beschrijving

HBOC Mutation Singular | Polymorphism

Datatype

boolean

Alias
UMLS CUI [1,1]
C0677776
UMLS CUI [1,2]
C0026882
UMLS CUI [1,3]
C0205171
UMLS CUI [2]
C1882417
Terug naar het begin van de pagina

Similar models

Eligibility Breast Cancer NCT02302742

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Triple Negative Breast Neoplasms
Item
triple negative breast cancer
boolean
C3539878 (UMLS CUI [1])
Estrogen Receptors Percentage | Progesterone Receptors Percentage | Human epidermal growth factor receptor negative
Item
er/pr <10% and her negative per current asco/cap guidelines
boolean
C0034804 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0034833 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C4087185 (UMLS CUI [3])
TNM Breast tumor staging
Item
stages i-iv
boolean
C0474926 (UMLS CUI [1])
Age
Item
any age at diagnosis
boolean
C0001779 (UMLS CUI [1])
Diagnosis Timespan
Item
patient must be within 5 years of diagnosis
boolean
C0011900 (UMLS CUI [1,1])
C0872291 (UMLS CUI [1,2])
Patient eligible for clinical trial Independent of Genetic testing
Item
eligible regardless of genetic testing status
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
Genetic testing Recommended
Item
genetic testing recommended for patients meeting nccn and medicare guidelines
boolean
C0679560 (UMLS CUI [1,1])
C0034866 (UMLS CUI [1,2])
ID.8
Item
and/or
boolean
Germ-Line Mutation Carrier
Item
germline mutation carriers
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Genes | BRCA gene | PTEN gene | TP53 gene | PALB2 gene | Patient eligible for clinical trial Independent of Cancer site
Item
patients with deleterious or uncertain mutations in hboc genes (brca, pten, p53,-palb2 etc) are eligible regardless of type/site of cancer
boolean
C0677776 (UMLS CUI [1,1])
C0017337 (UMLS CUI [1,2])
C0596223 (UMLS CUI [2])
C0694888 (UMLS CUI [3])
C0079419 (UMLS CUI [4])
C1835898 (UMLS CUI [5])
C1302261 (UMLS CUI [6,1])
C0332291 (UMLS CUI [6,2])
C0872338 (UMLS CUI [6,3])
Healthy Volunteers Mutation | Patient eligible for clinical trial
Item
healthy patients harboring mutations also eligible
boolean
C1708335 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C1302261 (UMLS CUI [2])
Time limit Absent | Cancer diagnosis | Enrollment
Item
there is no time limit from the time of diagnosis of cancer and enrollment.
boolean
C0332186 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0920688 (UMLS CUI [2])
C1516879 (UMLS CUI [3])
Patient eligible for clinical trial Independent of Cancer History
Item
eligible regardless of personal history of cancer
boolean
C1302261 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C1512706 (UMLS CUI [1,3])
Exclusion Criteria
Item
exclusion criteria include:
boolean
C0680251 (UMLS CUI [1])
Triple Negative Breast Neoplasm Previous
Item
triple negative breast cancer -patient is not within five years of diagnosis
boolean
C3539878 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Germ-Line Mutation Carrier
Item
germline mutation carriers:
boolean
C0206530 (UMLS CUI [1,1])
C2985478 (UMLS CUI [1,2])
HBOC Mutation Singular | Polymorphism
Item
patient only carries a hboc mutation that is classified as "polymorphism" of "favor polymorphism"
boolean
C0677776 (UMLS CUI [1,1])
C0026882 (UMLS CUI [1,2])
C0205171 (UMLS CUI [1,3])
C1882417 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial